INMED PHARMACEUTICAL

IN
Delayed Quote. Delayed  - 10/19 03:55:20 pm
4.76CAD +0.85%
Prev.4.7200
Open4.7000
High4.8300
Low4.5000
Volume2 511
Latest news
09/25
09/24
09/24
09/23
Chart INMED PHARMACEUTICALS INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance5,457,557,05
Spread/Res.-13%-37%-32%
Spread/Supp.11%11%11%
Support4,304,304,30
Financials
Sales 2021 - - -
Net income 2021 -15,3 M -11,6 M -11,6 M
Net Debt 2021 - - -
P/E ratio 2021 -2,40x
Yield 2021 -
Capitalization 24,9 M 18,9 M 18,8 M
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 11
Free-Float 98,8%
Company
InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis...

>> Read more
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-03 Earnings Release

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 14,85 CAD
Last Close Price 4,76 CAD
Spread / Highest target 212%
Spread / Average Target 212%
Spread / Lowest Target 212%